Mechanisms of Immune-Mediated Liver Injury
Open accessThe DOI matches its Crossref record; 121 of the 121 references it cites were found in a registry or an index.
Abstract
Hepatic inflammation is a common finding during a variety of liver diseases including drug-induced liver toxicity. The inflammatory phenotype can be attributed to the innate immune response generated by Kupffer cells, monocytes, neutrophils, and lymphocytes. The adaptive immune system is also influenced by the innate immune response leading to liver damage. This review summarizes recent advances in specific mechanisms of immune-mediated hepatotoxicity and its application to drug-induced liver injury. Basic mechanisms of activation of lymphocytes, macrophages, and neutrophils and their unique mechanisms of recruitment into the liver vasculature are discussed. In particular, the role of adhesion molecules and various inflammatory mediators in this process are explored. In addition, the authors describe mechanisms of liver cell damage by these inflammatory cells and critically evaluate the functional significance of each cell type for predictive and idiosyncratic drug-induced liver injury. It is expected that continued advances in our understanding of immune mechanisms of liver injury will lead to an earlier detection of the hepatotoxic potential of drugs under development and to an earlier identification of susceptible individuals at risk for predictive and idiosyncratic drug toxicities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mizgerd, J. P., Kubo, H., Kutkoski, G. J., Bhagwan, S. D., Scharffetter-Kochanek, K., Beaudet, A. L., & Doerschuk, C. M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1357 · Cited by 7,306
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation
Scaffidi, P., Misteli, T., & Bianchi, M. E. (2002) · Nature · doi:10.1038/nature00858 · Cited by 4,221 · cited 2×
“The resulting necrotic cell death leads to the release of DAMPs, which triggers cytokine formation and neutrophils accumulation (Chen et al., 2007; Imaeda et al., 2009; Scaffidi et al., 2002).”
BackgroundYang, Y., Li, S., Yang, Q., Shi, Y., Zheng, M., Liu, Y., Chen, F., Song, G., Xu, H., Wan, T., et al. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000358696 · Cited by 3,253
Fadok, V. A., Bratton, D. L., Konowal, A., Freed, P. W., Westcott, J. Y., & Henson, P. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1112 · Cited by 3,166 · cited 2×
“M1 macrophages generate proinflammatory cytokines and bacteriocidal mediators, whereas M2 cells play an important role in the downregulation of inflammation, tissue remodeling, elimination of tissue debris, and apoptotic bodies, as well as the induction of angiogenesis (Fadok et al., 1998; Goerdt and Orfanos, 1999).”
BackgroundHepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
Friedman, S. L. (2008) · Physiological Reviews · doi:10.1152/physrev.00013.2007 · Cited by 2,842 · cited 2×
“When activated, they are the major mediators of matrix formation in response to injury (Friedman, 2008) and also play a direct role in the inflammatory process (Holt et al., 2008a; Safadi et al., 2004).”
BackgroundDAMPs, PAMPs and alarmins: all we need to know about danger
Bianchi, M. E. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0306164 · Cited by 2,794 · cited 2×
“More recently, it was recognized that a number of intracellular proteins, for example, high-mobility group box-1 protein and heat shock proteins, as well as DNA and RNA fragments are also substrates for toll-like receptors and can trigger cytokine formation independent of infectious material (Bianchi, 2007).”
BackgroundOstapowicz, G., Fontana, R. J., Schiødt, F. V., Larson, A., Davern, T. J., Han, S. H. B., McCashland, T. M., Shakil, A. O., Hay, J. E., Hynan, L., et al. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-12-200212170-00007 · Cited by 2,227 · cited 1×
“Compared to other liver diseases, IDILI is more likely to develop into fulminant liver failure, accounting for more than 25% of cases in the ICU (Ostapowicz et al., 2002).”
BackgroundGardai, S. J., McPhillips, K. A., Frasch, S. C., Janssen, W. J., Starefeldt, A., Murphy-Ullrich, J. E., Bratton, D. L., Oldenborg, P.-A., Michalak, M., & Henson, P. M. (2005) · Cell · doi:10.1016/j.cell.2005.08.032 · Cited by 1,473
The Liver as an Immunological Organ
Racanelli, V., & Rehermann, B. (2006) · Hepatology · doi:10.1002/hep.21060 · Cited by 1,377
Jaeschke, H. (2002) · Toxicological Sciences · doi:10.1093/toxsci/65.2.166 · Cited by 1,304
Self-citation
Cited by
Godoy, P., Hewitt, N. J., Albrecht, U., Andersen, M. E., Ansari, N., Bhattacharya, S., Bode, J. G., Bolleyn, J., Borner, C., Böttger, J., et al. (2013) · Archives of Toxicology · doi:10.1007/s00204-013-1078-5 · Cited by 1,280
Self-citationJaeschke, H., McGill, M. R., & Ramachandran, A. (2012) · Drug Metabolism Reviews · doi:10.3109/03602532.2011.602688 · Cited by 964
Self-citationDu, K., Ramachandran, A., & Jaeschke, H. (2016) · Redox Biology · doi:10.1016/j.redox.2016.10.001 · Cited by 569
Self-citationAcetaminophen hepatotoxicity and repair: the role of sterile inflammation and innate immunity
Jaeschke, H., Williams, C. D., Ramachandran, A., & Bajt, M. L. (2012) · Liver International · doi:10.1111/j.1478-3231.2011.02501.x · Cited by 478
Self-citationManaging the challenge of chemically reactive metabolites in drug development
Park, B. K., Boobis, A., Clarke, S., Goldring, C. E. P., Jones, D., Kenna, J. G., Lambert, C., Laverty, H. G., Naisbitt, D. J., Nelson, S., et al. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3408 · Cited by 462
Mechanisms of Drug Toxicity and Relevance to Pharmaceutical Development
Guengerich, F. P. (2011) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.dmpk-10-rv-062 · Cited by 387
Molecular mechanisms underlying chemical liver injury
Gu, X., & Manautou, J. E. (2012) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399411002110 · Cited by 381
Liedtke, C., Luedde, T., Sauerbruch, T., Scholten, D., Streetz, K., Tacke, F., Tolba, R., Trautwein, C., Trebicka, J., & Weiskirchen, R. (2013) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-6-19 · Cited by 335
Pathogenesis of Idiosyncratic Drug-Induced Liver Injury and Clinical Perspectives
Fontana, R. J. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.12.032 · Cited by 313
HepaRG Cells: A Human Model to Study Mechanisms of Acetaminophen Hepatotoxicity Δσ
McGill, M. R., Yan, H.-M., Ramachandran, A., Murray, G. J., Rollins, D. E., & Jaeschke, H. (2011) · Hepatology · doi:10.1002/hep.24132 · Cited by 294
Self-citationKostadinova, R., Boess, F., Applegate, D., Suter, L., Weiser, T., Singer, T., Naughton, B., & Roth, A. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.01.012 · Cited by 262
Functional Role of Monocytes and Macrophages for the Inflammatory Response in Acute Liver Injury
Zimmermann, H. W., Trautwein, C., & Tacke, F. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00056 · Cited by 262
Deng, J., Wei, W., Chen, Z., Lin, B., Zhao, W., Luo, Y., & Zhang, X. (2019) · Micromachines · doi:10.3390/mi10100676 · Cited by 229
“Increasing evidence has revealed that these cells are closely related to immune-mediated hepatotoxicity [32].”
BackgroundLi, M., Sun, X., Zhao, J., Xia, L., Li, J., Xu, M., Wang, B., Guo, H., Yu, C., Gao, Y., et al. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-019-0279-0 · Cited by 225
Adverse events to monoclonal antibodies used for cancer therapy: Focus on hypersensitivity responses
Baldo, B. (2013) · OncoImmunology · doi:10.4161/onci.26333 · Cited by 191
Bogdanos, D. P., Gao, B., & Gershwin, M. E. (2013) · Comprehensive Physiology · doi:10.1002/cphy.c120011 · Cited by 185
Ilyas, G., Zhao, E., Liu, K., Lin, Y., Tesfa, L., Tanaka, K. E., & Czaja, M. J. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.08.019 · Cited by 144
“Although resident and recruited macrophages mediate the resolution and repair of liver damage, excessive macrophage activation underlies many forms of hepatocyte injury including that from the toxin alcohol and hepatic steatosis [2-4].”
BackgroundHuman biomimetic liver microphysiology systems in drug development and precision medicine
Gough, A., Soto-Gutierrez, A., Vernetti, L., Ebrahimkhani, M. R., Stern, A. M., & Taylor, D. L. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00386-1 · Cited by 117
The innate immune receptor TREM-1 promotes liver injury and fibrosis
Nguyen-Lefebvre, A. T., Ajith, A., Portik-Dobos, V., Horuzsko, D. D., Arbab, A. S., Dzutsev, A., Sadek, R., Trinchieri, G., & Horuzsko, A. (2018) · Journal of Clinical Investigation · doi:10.1172/jci98156 · Cited by 104
“In acute liver infections, inflammatory cell infiltration and hepatocellular damage are observed (8, 9).”
Towards improved hepatocyte cultures: Progress and limitations
Ruoß, M., Vosough, M., Königsrainer, A., Nadalin, S., Wagner, S., Sajadian, S., Huber, D., Heydari, Z., Ehnert, S., Hengstler, J. G., et al. (2020) · Food and Chemical Toxicology · doi:10.1016/j.fct.2020.111188 · Cited by 77
NAFLD and HBV interplay - related mechanisms underlying liver disease progression
Tourkochristou, E., Assimakopoulos, S. F., Thomopoulos, K., Marangos, M., & Triantos, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.965548 · Cited by 70
“NAFLD has been remarked as causative agent of elevated ALT enzyme with a rate of 25%, in CHB patients (12).”
BackgroundBenesic, A., Leitl, A., & Gerbes, A. L. (2016) · Gut · doi:10.1136/gutjnl-2015-309528 · Cited by 48
Brink, A., Pähler, A., Funk, C., Schuler, F., & Schadt, S. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2016.11.018 · Cited by 42
Recent advances in models of immune-mediated drug-induced liver injury
Tasnim, F., Huang, X., Lee, C. Z. W., Ginhoux, F., & Yu, H. (2021) · Frontiers in Toxicology · doi:10.3389/ftox.2021.605392 · Cited by 32
Sun, B., Liang, Z., Wang, Y., Yu, Y., Zhou, X., Geng, X., & Li, B. (2024) · Toxicology · doi:10.1016/j.tox.2024.153829 · Cited by 30
Dissecting the single-cell transcriptome underlying chronic liver injury
Wang, J., Hu, W., Shen, Z., Liu, T., Dai, W., Shen, B., Li, X., Wu, J., Lu, L., Li, S., et al. (2021) · Molecular Therapy - Nucleic Acids · doi:10.1016/j.omtn.2021.11.008 · Cited by 26
Drug-mediated toxicity: illuminating the ‘bad’ in the test tube by means of cellular assays?
Tralau, T., & Luch, A. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.03.015 · Cited by 24
Abbas, N., You, K., Getachew, A., Wu, F., Hussain, M., Huang, X., Chen, Y., Pan, T., & Li, Y. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-03656-w · Cited by 5
“A key pathological feature of the overwhelming liver damage is the massive mobilization of innate and adaptive immune responses leading to acute liver failure [1, 2].”
Background
Metadata
- Authors
- Adams, D. H., Ju, C., Ramaiah, S. K., Uetrecht, J., & Jaeschke, H.
- Venue
- Toxicological Sciences
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-01-13
- Volume
- 115
- Issue
- 2
- Pages
- 307-321
- ISSN
- 1096-0929 (ISSN-L)
- 1096-6080
- OpenAlex
- W2026488328
- Cited by
- 298
- References
- 121
- FWCI
- 24.70
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.